• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泰-萨克斯病(一种罕见的儿科疾病)患者的护理计划

Nursing Care Plan for Patients with Tay-Sachs-A Rare Paediatric Disease.

作者信息

Cortés-Martín Jonathan, Piqueras-Sola Beatriz, Sánchez-García Juan Carlos, Reinoso-Cobo Andrés, Ramos-Petersen Laura, Díaz-Rodríguez Lourdes, Rodríguez-Blanque Raquel

机构信息

Research Group CTS1068, Andalusia Research Plan, Junta de Andalucía, Nursing Department, Faculty of Health Sciences, University of Granada, 18071 Granada, Spain.

Hospital University Virgen de las Nieves, 18014 Granada, Spain.

出版信息

J Pers Med. 2023 Aug 1;13(8):1222. doi: 10.3390/jpm13081222.

DOI:10.3390/jpm13081222
PMID:37623472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10455330/
Abstract

Tay-Sachs disease is classified as a rare paediatric disease of metabolic origin. It is an autosomal recessive inherited disease. The gene responsible for the disease is known as HEXA, and it is located on chromosome 15(15q23). There is currently no effective treatment for Tay-Sachs disease; hence, it is an incurable disease in which patients do not live for more than five years, meaning that nursing care takes on greater importance to maintain quality of life. The main objective of this work is to develop a specific standard nursing care plan by applying an inductive research method supported by nursing methodology using the NANDA-NIC-NOC taxonomy and validated by the Delphi method. This care plan will improve the knowledge of health professionals on this topic and support future studies on the disease. Following its implementation, the care plan proposed in this study aims to increase the quality of life of patients diagnosed with this disease.

摘要

泰-萨克斯病被归类为一种罕见的代谢性儿科疾病。它是一种常染色体隐性遗传病。导致该疾病的基因名为HEXA,位于15号染色体(15q23)上。目前尚无治疗泰-萨克斯病的有效方法;因此,它是一种不治之症,患者存活时间不超过五年,这意味着护理对于维持生活质量更为重要。本研究的主要目的是通过采用以护理方法学为支撑的归纳研究方法,运用NANDA-NIC-NOC分类法并经德尔菲法验证,制定一份特定的标准护理计划。该护理计划将提高医护人员对这一主题的认识,并为该疾病的未来研究提供支持。本研究提出的护理计划在实施后旨在提高被诊断患有这种疾病的患者的生活质量。

相似文献

1
Nursing Care Plan for Patients with Tay-Sachs-A Rare Paediatric Disease.泰-萨克斯病(一种罕见的儿科疾病)患者的护理计划
J Pers Med. 2023 Aug 1;13(8):1222. doi: 10.3390/jpm13081222.
2
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.地中海贫血、镰状细胞病、囊性纤维化和泰萨二氏病的孕前风险评估。
Cochrane Database Syst Rev. 2021 Oct 11;10(10):CD010849. doi: 10.1002/14651858.CD010849.pub4.
3
New Approaches to Tay-Sachs Disease Therapy.泰-萨克斯病治疗的新方法。
Front Physiol. 2018 Nov 20;9:1663. doi: 10.3389/fphys.2018.01663. eCollection 2018.
4
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.地中海贫血、镰状细胞病、囊性纤维化和泰-萨克斯病的孕前风险评估。
Cochrane Database Syst Rev. 2015 Aug 12;2015(8):CD010849. doi: 10.1002/14651858.CD010849.pub2.
5
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.地中海贫血、镰状细胞病、囊性纤维化和泰-萨克斯病的孕前风险评估。
Cochrane Database Syst Rev. 2018 Mar 14;3(3):CD010849. doi: 10.1002/14651858.CD010849.pub3.
6
Evaluation of child with asthma and her caregivers based on the Pender health promotion model, and linkages of NANDA, NIC-NOC: A case presentation.基于彭德健康促进模式对哮喘患儿及其照顾者的评估,以及北美护理诊断协会、护理干预分类-护理结局分类的联系:病例报告
Int J Nurs Knowl. 2025 Apr;36(2):169-182. doi: 10.1111/2047-3095.12472. Epub 2024 May 27.
7
Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease.用于泰萨二氏病的疾病建模和治疗评估的神经干细胞。
Orphanet J Rare Dis. 2018 Sep 17;13(1):152. doi: 10.1186/s13023-018-0886-3.
8
Tay-Sachs Disease: Two Novel Rare HEXA Mutations from Pakistan and Morocco.泰萨二氏病:来自巴基斯坦和摩洛哥的两种新型罕见 HEXA 突变。
Klin Padiatr. 2021 Sep;233(5):226-230. doi: 10.1055/a-1371-1561. Epub 2021 Apr 8.
9
Autophagic flux is impaired in the brain tissue of Tay-Sachs disease mouse model.自噬通量在泰-萨克斯病小鼠模型的脑组织中受损。
PLoS One. 2023 Mar 16;18(3):e0280650. doi: 10.1371/journal.pone.0280650. eCollection 2023.
10
Biochemical and mutational analyses of HEXA in a cohort of Egyptian patients with infantile Tay-Sachs disease. Expansion of the mutation spectrum.对一组埃及婴儿型泰萨二氏病患者的 HEXA 进行生化和突变分析。扩展突变谱。
Orphanet J Rare Dis. 2023 Mar 13;18(1):52. doi: 10.1186/s13023-023-02637-1.

引用本文的文献

1
Deciphering the Complexity of FSHD: A Multimodal Approach as a Model for Rare Disorders.解析 FSHD 的复杂性:一种多模态方法作为罕见疾病的模型。
Int J Mol Sci. 2024 Oct 11;25(20):10949. doi: 10.3390/ijms252010949.

本文引用的文献

1
Late-Onset Tay-Sachs Disease - expanding the clinical phenotype.迟发性泰-萨克斯病——扩展临床表型
Tremor Other Hyperkinet Mov (N Y). 2023 Jan 31;13:4. doi: 10.5334/tohm.750. eCollection 2023.
2
Diagnostic Tips from a Video Series and Literature Review of Patients with Late-Onset Tay-Sachs Disease.从视频系列和文献回顾中诊断晚期泰-萨克斯病患者的技巧。
Tremor Other Hyperkinet Mov (N Y). 2022 Dec 27;12:34. doi: 10.5334/tohm.726. eCollection 2022.
3
GM1-gangliosidosis: The caregivers' assessments of symptom impact and most important symptoms to treat.GM1 神经节苷脂贮积症:照料者对症状影响的评估以及最需要治疗的症状。
Am J Med Genet A. 2023 Feb;191(2):408-423. doi: 10.1002/ajmg.a.63038. Epub 2022 Dec 21.
4
Clinical and Laboratory Profile of Gangliosidosis from Southern Part of India.印度南部神经节苷脂贮积症的临床和实验室特征
J Pediatr Genet. 2020 Oct 19;11(1):34-41. doi: 10.1055/s-0040-1718726. eCollection 2022 Mar.
5
AAV gene therapy for Tay-Sachs disease.腺相关病毒基因治疗泰萨二氏病。
Nat Med. 2022 Feb;28(2):251-259. doi: 10.1038/s41591-021-01664-4. Epub 2022 Feb 10.
6
Rare coexistence of Tay-Sachs disease, coarctation of the aorta and grade V vesicoureteral reflux.泰萨二氏病、主动脉缩窄与 5 级膀胱输尿管反流并存罕见。
Arch Argent Pediatr. 2022 Feb;120(1):e25-e28. doi: 10.5546/aap.2022.eng.e25. Epub 2022 Jan 1.
7
[Rehabilitation in Tay-Sachs disease: A case report].[泰-萨克斯病的康复治疗:一例报告]
Rehabilitacion (Madr). 2022 Apr-Jun;56(2):164-167. doi: 10.1016/j.rh.2020.10.010. Epub 2021 Apr 6.
8
Tay-Sachs Disease: Two Novel Rare HEXA Mutations from Pakistan and Morocco.泰萨二氏病:来自巴基斯坦和摩洛哥的两种新型罕见 HEXA 突变。
Klin Padiatr. 2021 Sep;233(5):226-230. doi: 10.1055/a-1371-1561. Epub 2021 Apr 8.
9
Two patients from Turkey with a novel variant in the gene and review of the literature.两例土耳其患者携带新型基因变异,文献复习。
J Pediatr Endocrinol Metab. 2021 Apr 6;34(6):805-812. doi: 10.1515/jpem-2020-0655. Print 2021 Jun 25.
10
Novel HEXA variants in Korean children with Tay-Sachs disease with regression of neurodevelopment from infancy.新型 HEXA 变异导致韩国婴儿期发病的泰萨二氏症患儿神经发育倒退。
Mol Genet Genomic Med. 2021 Jun;9(6):e1677. doi: 10.1002/mgg3.1677. Epub 2021 Apr 3.